FBR Capital Maintains an 'Outperform' on Core Laboratories (CLB); Trimming Estimates on 1Q Disruptions
Tweet Send to a Friend
FBR Capital maintains an 'Outperform' on Core Laboratories (NYSE: CLB), PT $120.
FBR analyst says, "We are trimming our 2011 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "We are trimming our 2011 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
